Logo image of 6D81.DE

DUPONT DE NEMOURS INC (6D81.DE) Stock Fundamental Analysis

FRA:6D81 - Deutsche Boerse Ag - US26614N1028 - Common Stock - Currency: EUR

64.5  +0.07 (+0.11%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 6D81. 6D81 was compared to 67 industry peers in the Chemicals industry. Both the profitability and the financial health of 6D81 get a neutral evaluation. Nothing too spectacular is happening here. 6D81 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year 6D81 was profitable.
In the past year 6D81 had a positive cash flow from operations.
6D81 had positive earnings in 4 of the past 5 years.
In the past 5 years 6D81 always reported a positive cash flow from operatings.
6D81.DE Yearly Net Income VS EBIT VS OCF VS FCF6D81.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

With a Return On Assets value of -0.21%, 6D81 perfoms like the industry average, outperforming 43.28% of the companies in the same industry.
Looking at the Return On Equity, with a value of -0.33%, 6D81 is in line with its industry, outperforming 43.28% of the companies in the same industry.
With a decent Return On Invested Capital value of 4.51%, 6D81 is doing good in the industry, outperforming 62.69% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 6D81 is below the industry average of 6.29%.
The last Return On Invested Capital (4.51%) for 6D81 is above the 3 year average (3.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.21%
ROE -0.33%
ROIC 4.51%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
6D81.DE Yearly ROA, ROE, ROIC6D81.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

6D81's Profit Margin has improved in the last couple of years.
6D81's Operating Margin of 17.31% is amongst the best of the industry. 6D81 outperforms 89.55% of its industry peers.
6D81's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 37.26%, 6D81 is in line with its industry, outperforming 58.21% of the companies in the same industry.
6D81's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.31%
PM (TTM) N/A
GM 37.26%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
6D81.DE Yearly Profit, Operating, Gross Margins6D81.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 6D81 is destroying value.
6D81 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 6D81 has less shares outstanding
Compared to 1 year ago, 6D81 has an improved debt to assets ratio.
6D81.DE Yearly Shares Outstanding6D81.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
6D81.DE Yearly Total Debt VS Total Assets6D81.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

6D81 has an Altman-Z score of 1.13. This is a bad value and indicates that 6D81 is not financially healthy and even has some risk of bankruptcy.
6D81 has a worse Altman-Z score (1.13) than 76.12% of its industry peers.
6D81 has a debt to FCF ratio of 6.43. This is a slightly negative value and a sign of low solvency as 6D81 would need 6.43 years to pay back of all of its debts.
6D81 has a Debt to FCF ratio of 6.43. This is in the better half of the industry: 6D81 outperforms 68.66% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that 6D81 is not too dependend on debt financing.
6D81 has a better Debt to Equity ratio (0.23) than 70.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 6.43
Altman-Z 1.13
ROIC/WACC0.54
WACC8.41%
6D81.DE Yearly LT Debt VS Equity VS FCF6D81.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 1.40 indicates that 6D81 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, 6D81 is doing worse than 65.67% of the companies in the same industry.
6D81 has a Quick Ratio of 1.40. This is a bad value and indicates that 6D81 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.91, 6D81 is not doing good in the industry: 67.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.91
6D81.DE Yearly Current Assets VS Current Liabilites6D81.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

4

3. Growth

3.1 Past

6D81 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.66%, which is quite impressive.
Measured over the past years, 6D81 shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.50% on average per year.
The Revenue has been growing slightly by 4.51% in the past year.
6D81 shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.31% yearly.
EPS 1Y (TTM)25.66%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%30.38%
Revenue 1Y (TTM)4.51%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%4.61%

3.2 Future

The Earnings Per Share is expected to grow by 8.20% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.21% on average over the next years.
EPS Next Y8.18%
EPS Next 2Y8.69%
EPS Next 3Y9.37%
EPS Next 5Y8.2%
Revenue Next Year3.34%
Revenue Next 2Y3.87%
Revenue Next 3Y4.28%
Revenue Next 5Y4.21%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
6D81.DE Yearly Revenue VS Estimates6D81.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B
6D81.DE Yearly EPS VS Estimates6D81.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.48, 6D81 is valued on the expensive side.
Based on the Price/Earnings ratio, 6D81 is valued a bit cheaper than the industry average as 68.66% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of 6D81 to the average of the S&P500 Index (27.19), we can say 6D81 is valued slightly cheaper.
The Price/Forward Earnings ratio is 15.68, which indicates a correct valuation of 6D81.
Based on the Price/Forward Earnings ratio, 6D81 is valued a bit cheaper than 61.19% of the companies in the same industry.
6D81's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.33.
Industry RankSector Rank
PE 17.48
Fwd PE 15.68
6D81.DE Price Earnings VS Forward Price Earnings6D81.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 6D81.
6D81's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 28.3
EV/EBITDA 10.98
6D81.DE Per share data6D81.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 6D81 does not grow enough to justify the current Price/Earnings ratio.
6D81 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.14
PEG (5Y)N/A
EPS Next 2Y8.69%
EPS Next 3Y9.37%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.15%, 6D81 has a reasonable but not impressive dividend return.
6D81's Dividend Yield is a higher than the industry average which is at 2.99.
Compared to an average S&P500 Dividend Yield of 2.35, 6D81 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.15%

5.2 History

The dividend of 6D81 decreases each year by -33.98%.
Dividend Growth(5Y)-33.98%
Div Incr Years4
Div Non Decr Years4
6D81.DE Yearly Dividends per share6D81.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of 6D81 are negative and hence is the payout ratio. 6D81 will probably not be able to sustain this dividend level.
DP-864%
EPS Next 2Y8.69%
EPS Next 3Y9.37%
6D81.DE Yearly Income VS Free CF VS Dividend6D81.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

DUPONT DE NEMOURS INC

FRA:6D81 (7/15/2025, 7:00:00 PM)

64.5

+0.07 (+0.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners73.2%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap26.99B
Analysts81.54
Price Target75.65 (17.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.15%
Yearly Dividend1.28
Dividend Growth(5Y)-33.98%
DP-864%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.49%
Min EPS beat(2)4.98%
Max EPS beat(2)11.99%
EPS beat(4)4
Avg EPS beat(4)9.71%
Min EPS beat(4)4.98%
Max EPS beat(4)11.99%
EPS beat(8)6
Avg EPS beat(8)7.8%
EPS beat(12)10
Avg EPS beat(12)7.42%
EPS beat(16)14
Avg EPS beat(16)7.74%
Revenue beat(2)0
Avg Revenue beat(2)-2.15%
Min Revenue beat(2)-2.15%
Max Revenue beat(2)-2.14%
Revenue beat(4)1
Avg Revenue beat(4)-1.65%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)0.96%
Revenue beat(8)2
Avg Revenue beat(8)-2%
Revenue beat(12)3
Avg Revenue beat(12)-1.6%
Revenue beat(16)3
Avg Revenue beat(16)-5.68%
PT rev (1m)-1.04%
PT rev (3m)-18.97%
EPS NQ rev (1m)0.46%
EPS NQ rev (3m)-3.05%
EPS NY rev (1m)0.53%
EPS NY rev (3m)-2.28%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-0.28%
Valuation
Industry RankSector Rank
PE 17.48
Fwd PE 15.68
P/S 2.52
P/FCF 28.3
P/OCF 18.18
P/B 1.38
P/tB 19.29
EV/EBITDA 10.98
EPS(TTM)3.69
EY5.72%
EPS(NY)4.11
Fwd EY6.38%
FCF(TTM)2.28
FCFY3.53%
OCF(TTM)3.55
OCFY5.5%
SpS25.59
BVpS46.67
TBVpS3.34
PEG (NY)2.14
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.21%
ROE -0.33%
ROCE 6.92%
ROIC 4.51%
ROICexc 4.78%
ROICexgc 16.87%
OM 17.31%
PM (TTM) N/A
GM 37.26%
FCFM 8.91%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
ROICexc(3y)3.85%
ROICexc(5y)3.28%
ROICexgc(3y)12.84%
ROICexgc(5y)9.92%
ROCE(3y)5.39%
ROCE(5y)4.66%
ROICexcg growth 3Y25.22%
ROICexcg growth 5Y11.83%
ROICexc growth 3Y9.23%
ROICexc growth 5Y14.61%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 6.43
Debt/EBITDA 1.58
Cap/Depr 51.92%
Cap/Sales 4.96%
Interest Coverage 250
Cash Conversion 51.61%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.91
Altman-Z 1.13
F-Score5
WACC8.41%
ROIC/WACC0.54
Cap/Depr(3y)55.14%
Cap/Depr(5y)53.03%
Cap/Sales(3y)5.17%
Cap/Sales(5y)6.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.66%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%30.38%
EPS Next Y8.18%
EPS Next 2Y8.69%
EPS Next 3Y9.37%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.51%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%4.61%
Revenue Next Year3.34%
Revenue Next 2Y3.87%
Revenue Next 3Y4.28%
Revenue Next 5Y4.21%
EBIT growth 1Y28.13%
EBIT growth 3Y0.11%
EBIT growth 5Y-0.66%
EBIT Next Year29.61%
EBIT Next 3Y14.01%
EBIT Next 5Y11.26%
FCF growth 1Y10236.4%
FCF growth 3Y-3.02%
FCF growth 5YN/A
OCF growth 1Y140.44%
OCF growth 3Y-6.79%
OCF growth 5Y5.56%